Umesh Dashora

1.0k total citations · 1 hit paper
52 papers, 547 citations indexed

About

Umesh Dashora is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Umesh Dashora has authored 52 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Umesh Dashora's work include Diabetes Management and Research (23 papers), Diabetes Treatment and Management (20 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers). Umesh Dashora is often cited by papers focused on Diabetes Management and Research (23 papers), Diabetes Treatment and Management (20 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers). Umesh Dashora collaborates with scholars based in United Kingdom, United States and Spain. Umesh Dashora's co-authors include Dipesh Patel, Marc Evans, Ketan Dhatariya, Sarah Davies, Zaheer Yousef, Angharad R. Morgan, Simon Ashwell, W. David Strain, Stephen C. Bain and Wasim Hanif and has published in prestigious journals such as Annals of the New York Academy of Sciences, BMJ and Drugs.

In The Last Decade

Umesh Dashora

45 papers receiving 533 citations

Hit Papers

A Narrative Review of Chronic Kidney Disease in Clinical ... 2021 2026 2022 2024 2021 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
    2021 149 citations Marc Evans, Angharad R. Morgan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umesh Dashora United Kingdom 11 344 153 108 87 77 52 547
Cristian Serafinceanu Romania 12 267 0.8× 81 0.5× 39 0.4× 26 0.3× 109 1.4× 42 529
T A Chowdhury United Kingdom 12 265 0.8× 66 0.4× 74 0.7× 30 0.3× 39 0.5× 20 466
Valeria Frighi United Kingdom 11 230 0.7× 124 0.8× 87 0.8× 101 1.2× 109 1.4× 16 584
G Lloveras Spain 9 183 0.5× 174 1.1× 84 0.8× 26 0.3× 34 0.4× 19 440
R. Boizel France 9 337 1.0× 173 1.1× 50 0.5× 50 0.6× 35 0.5× 18 523
Jiemin Pan China 16 255 0.7× 146 1.0× 41 0.4× 14 0.2× 83 1.1× 34 574
Rachid Malek Algeria 11 375 1.1× 68 0.4× 46 0.4× 22 0.3× 60 0.8× 50 583
Wing-Bun Chan Hong Kong 8 256 0.7× 104 0.7× 20 0.2× 44 0.5× 39 0.5× 10 502
Donají Gómez‐Velasco Mexico 10 372 1.1× 72 0.5× 37 0.3× 41 0.5× 70 0.9× 22 717
Marcelo Aizpurúa Argentina 12 359 1.0× 155 1.0× 23 0.2× 30 0.3× 41 0.5× 16 588

Countries citing papers authored by Umesh Dashora

Since Specialization
Citations

This map shows the geographic impact of Umesh Dashora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umesh Dashora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umesh Dashora more than expected).

Fields of papers citing papers by Umesh Dashora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umesh Dashora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umesh Dashora. The network helps show where Umesh Dashora may publish in the future.

Co-authorship network of co-authors of Umesh Dashora

This figure shows the co-authorship network connecting the top 25 collaborators of Umesh Dashora. A scholar is included among the top collaborators of Umesh Dashora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umesh Dashora. Umesh Dashora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinclair, Alexandra J., Srikanth Bellary, Rosemary Walker, et al.. (2024). Type 1 Diabetes in care homes: A practical guide on management. Diabetic Medicine. 42(3). e15457–e15457.
2.
Dashora, Umesh, et al.. (2023). Optimal staffing for a good quality inpatient diabetes service. Diabetic Medicine. 40(10). e15151–e15151. 3 indexed citations
3.
Sinclair, Alan J., Srikanth Bellary, Umesh Dashora, et al.. (2023). Enhancing diabetes care for the most vulnerable in the 21st century: Interim findings of the National Advisory Panel on Care Home Diabetes (NAPCHD). Diabetic Medicine. 40(8). e15088–e15088. 3 indexed citations
4.
Evans, Marc, Angharad R. Morgan, Stephen C. Bain, et al.. (2022). Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice. Diabetes Therapy. 13(2). 225–240. 7 indexed citations
5.
Evans, Marc, Angharad R. Morgan, Stephen C. Bain, et al.. (2022). Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently. Diabetes Therapy. 13(5). 889–911. 5 indexed citations
6.
Мустафа, Омар, et al.. (2022). Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabetic Medicine. 40(3). e15005–e15005. 27 indexed citations
7.
Evans, Marc, Angharad R. Morgan, Martin Whyte, et al.. (2021). New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice. Drugs. 82(2). 97–108. 9 indexed citations
8.
Evans, Marc, Angharad R. Morgan, Zaheer Yousef, et al.. (2021). Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors. Drugs. 81(11). 1243–1255. 3 indexed citations
9.
10.
11.
Evans, Marc, Debbie Hicks, Dipesh Patel, et al.. (2019). Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes. Diabetes Therapy. 11(1). 37–52. 36 indexed citations
12.
Dashora, Umesh, et al.. (2018). The Rowan Hillson Inpatient Diabetes Safety Award 2017 for the best digital initiative. British Journal of Diabetes. 18(3). 110–112. 4 indexed citations
13.
14.
Dashora, Umesh, et al.. (2014). Hypoglycaemia in a patient who is non-diabetic. BMJ Case Reports. 2014. bcr2013203260–bcr2013203260. 2 indexed citations
15.
Dashora, Umesh, et al.. (2012). Diabetes in the young but not needing insulin – what type is it?. BMJ Case Reports. 2012. bcr1120115127–bcr1120115127.
16.
Dashora, Umesh, et al.. (2011). Ketoacidosis in type 2 diabetes- is it type 1 and ½ diabetes?. BMJ Case Reports. 2011. bcr0720114460–bcr0720114460. 9 indexed citations
17.
Dashora, Umesh, Simon Ashwell, & P. D. Home. (2009). An exploratory study of the effect of using high‐mix biphasic insulin aspart in people with type 2 diabetes. Diabetes Obesity and Metabolism. 11(7). 680–687. 10 indexed citations
18.
Dashora, Umesh, Latika Sibal, Simon Ashwell, & P. D. Home. (2007). Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial. Diabetic Medicine. 24(4). 344–349. 12 indexed citations
19.
Ashwell, Simon, Stephanie A. Amiel, R. W. Bilous, et al.. (2006). Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes. Diabetic Medicine. 23(3). 285–292. 87 indexed citations
20.
Sibal, Latika, et al.. (2006). Predicting the Development of Macrovascular Disease in People with Type 1 Diabetes. Annals of the New York Academy of Sciences. 1084(1). 191–207. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristian Serafinceanu Breakdown of academic impact, for papers by T A Chowdhury Breakdown of academic impact, for papers by Valeria Frighi Breakdown of academic impact, for papers by G Lloveras Breakdown of academic impact, for papers by R. Boizel Breakdown of academic impact, for papers by Jiemin Pan Breakdown of academic impact, for papers by Rachid Malek Breakdown of academic impact, for papers by Wing-Bun Chan Breakdown of academic impact, for papers by Donají Gómez‐Velasco Breakdown of academic impact, for papers by Marcelo Aizpurúa
Rankless by CCL
2026